US FDA appeals against court ruling that Myblu can remain on sale pending review

The US Food and Drug Administration (FDA) has hit back at a court-issued stay allowing Fontem’s Myblu vaping products to continue to be legally sold in the US.

The agency has argued that the Tobacco Control Act makes Fontem’s products unlawful to be sold without market authorisation. It says all a court can do is return a marketing denial order (MDO) to the FDA for review and that while that review is taking place, products cannot be legally sold.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ US FDA appeals against court ruling that Myblu can remain on sale pending review ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ US FDA appeals against court ruling that Myblu can remain on sale pending review ”






      The US Food and Drug Administration (FDA) has hit back at a court-issued stay allowing Fontem’s Myblu vaping products to continue to be legally sold in the US.

      The agency has argued that the Tobacco Control Act makes Fontem’s products unlawful to be sold without market authorisation. It says all a court can do is return a marketing denial order (MDO) to the FDA for review and that while that review is taking place, products cannot be legally sold.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik